Boost for UK’s life sciences sector as West Yorkshire hosts England’s third Investment Zone
Dedalus supports major investment across West Yorkshire
The government has today (20 November) launched England’s third Investment Zone in West Yorkshire focussed on Huddersfield, Bradford and Leeds, which will help to create more than 2,500 new jobs across the region over the next five years, and could unlock £220 million in investment.
- West Yorkshire’s new Investment Zone focused on Huddersfield, Bradford and Leeds could create more than 2,500 new jobs over five years across the region and unlock over £220 million of investment.
- Initial investment from a health tech company that supports patients to minimize hair loss during chemotherapy.
- Chancellor to extend the programme of Investment Zones from five to 10 years and double the envelope of funding and tax reliefs on offer.
-
Digital healthcare company Dedalus is investing £21 million to deliver digital and diagnostic tools for the NHS.
As one of the three businesses that make up the core announcement, West Yorkshire Combined Authority visited at our offices at Nexus and Sovereign Street in Leeds to learn more about what we do and our operations. They met with Richard Lilley who spoke more about our job offerings, our apprentice intake, and our plans for the future.
Daryll Goodall, Managing Director UK and Ireland at Dedalus, said:
“We are delighted to be a key part of the West Yorkshire Investment Zone. As a Global Healthcare company, Dedalus work closely with local Universities and Hospital Trusts in the West Yorkshire area to help bring new products from Europe to the UK healthcare market, and using our team in Leeds we develop products specifically for the UK.
“We are excited about the future, having the opportunity to implement our ORBIS electronic patient record (EPR) in the UK, and continuing to develop local healthcare applications like OneResponse, a mobile EPR for ambulance services in the UK, and PatientAide, a mobile app for clinicians providing them with access to key services and patient information.”